Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 57967263 | HCID 57967263 | — |
| Solvent | Trifluoroacetic acid | HCID 6422 | — |
| Product | Glesatinib | HCID 25181472 | 63% |
Reaction Steps
To solid 14 (7.00 g, 9.72 mmol) in a 250 mL round-bottom flask was added TFA (20 mL). The addition was a little bit exothermic. The mixture was stirred at r.t. for 2 h then concentrated and co-evaporated with MTBE (2×100 mL) to obtain a solid that was triturated with MTBE (80 mL) for 2 h. The solid was collected by filtration, washed with MTBE (2×10 mL) and dried in vacuum for 1 h. The dry solid was partitioned between the mixture of DCM/MeOH: (9/1, 300 mL) and NaHCO3 (200 mL). The phases were separated. The organic phase was collected and the aqueous phase was extracted with DCM/MeOH: 9/1 (2×150 mL). Organic phases were combined, washed with brine (100 mL), dried over Na2SO4 and concentrated. The solid residue was triturated with EA (40 mL) for 1 h, collected by filtration, washed with EA (2×5 mL), dried in vacuum for 1 h to afford 15 as beige solid (3.77 g, 63% yield). MS (m/z): 620.6 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08907091B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-91d08539e5c94d71944d4d278f4257de |
|---|
| Source note | uspto-grants-2014_12 |
|---|